0
Skip to Content
Health Business Group
Growth Strategy
Due Diligence for Transactions
Tech-enabled Healthcare Services
Life Sciences
Digital Health and Health IT
Private Equity/Investors
Consultants
Case Studies
History
Testimonials
Podcast
Media Room
blog
Contact
Health Business Group
Growth Strategy
Due Diligence for Transactions
Tech-enabled Healthcare Services
Life Sciences
Digital Health and Health IT
Private Equity/Investors
Consultants
Case Studies
History
Testimonials
Podcast
Media Room
blog
Contact
Folder: Services ▾
Back
Growth Strategy
Due Diligence for Transactions
Folder: Sectors ▾
Back
Tech-enabled Healthcare Services
Life Sciences
Digital Health and Health IT
Private Equity/Investors
Folder: About ▾
Back
Consultants
Case Studies
History
Testimonials
Podcast
Media Room
blog
Contact
Economics, Health plans, Pharma 5/9/07 Economics, Health plans, Pharma 5/9/07

When a $0 copay is too high

Read More
Economics, Pharma, Policy and politics, Technology 5/9/07 Economics, Pharma, Policy and politics, Technology 5/9/07

Sauce for the goose and gander in biotech

Read More
Economics, Pharma, Policy and politics 5/8/07 Economics, Pharma, Policy and politics 5/8/07

Credibility and prosperity in biotech

Read More
Economics, Pharma, Policy and politics 5/3/07 Economics, Pharma, Policy and politics 5/3/07

A somewhat more compelling take on biogenerics from Express Scripts

Read More
e-health, Pharma, Podcast 5/2/07 e-health, Pharma, Podcast 5/2/07

Podcast interview with Donato Tramuto, President of Physicians Interactive

Read More
Economics, Pharma, Policy and politics 5/1/07 Economics, Pharma, Policy and politics 5/1/07

Nice work if you can get it

Read More
Economics, International, Pharma, Policy and politics 4/30/07 Economics, International, Pharma, Policy and politics 4/30/07

Free ridin'

Read More
Pharma, Policy and politics 4/17/07 Pharma, Policy and politics 4/17/07

Senator Clinton does us a favor

Read More
Pharma, Physicians, Policy and politics 4/17/07 Pharma, Physicians, Policy and politics 4/17/07

Good Op-Ed on conflicts of interest

Read More
Health plans, Pharma 4/11/07 Health plans, Pharma 4/11/07

You can't keep a good drug down

Read More
Pharma, Physicians 4/11/07 Pharma, Physicians 4/11/07

Tips for pharma consumers

Read More
Economics, Pharma, Policy and politics 4/9/07 Economics, Pharma, Policy and politics 4/9/07

Paradox or idiocy?

Read More
Economics, Health plans, Pharma 3/22/07 Economics, Health plans, Pharma 3/22/07

The right idea on generic co-pays

Read More
Economics, Health plans, Pharma 3/20/07 Economics, Health plans, Pharma 3/20/07

Upgrade or downgrade?

Read More
Pharma, Policy and politics, Uncategorized 3/16/07 Pharma, Policy and politics, Uncategorized 3/16/07

Why bother?

Read More
Pharma 3/14/07 Pharma 3/14/07

Rage against the machine

Read More
Economics, Pharma 3/13/07 Economics, Pharma 3/13/07

Eye-popping generic pricing disparities

Read More
Entrepreneurs, International, Pharma 3/9/07 Entrepreneurs, International, Pharma 3/9/07

Reimportation and Zionism

Read More
Economics, Pharma, Policy and politics 3/7/07 Economics, Pharma, Policy and politics 3/7/07

Senators still seem to be missing the point on generic biologics

Read More
Announcements, Blogs, Pharma 3/7/07 Announcements, Blogs, Pharma 3/7/07

Live broadcast with Myogen founder Mike Bristow, MD tomorrow

Read More
Newer Posts
Older Posts

SERVICES

Growth StrategyDue Diligence for Transactions

SECTORS

Tech-enabled Healthcare Services
Life Sciences

Digital Health and Health IT
Private Equity/Investors

ABOUT

Consultants
Case Studies
History
Testimonials

Media Room
Blog
Contact

101 Federal St., S. 1900 | Boston, MA 02110 | (617) 731-3182

© 2026 Health Business Group. All Rights Reserved.